Table 1 Clinical characteristics of total cohort.
Characteristics | Non-infected (n = 157) | Infected (n = 57) | Suspected (n = 140) |
|---|---|---|---|
Age, median (1st, 3rd quartile) | 55 (47, 61) | 51 (42, 61) | 56 (48.25, 63) |
Sex, Males, n (%) | 61 (38.9) | 30 (52.6) | 61 (43.6) |
Tobacco, n (%) | 21 (13.4) | 8 (14.0) | 24 (17.1) |
Alcoholism, n (%) | 14 (8.9) | 4 (7.0) | 19 (13.6) |
Hypertension, n (%) | 36(22.9) | 15 (26.3) | 37 (26.4) |
Diabetes, n (%) | 12 (7.6) | 7 (12.3) | 15 (10.7) |
BMI*, > 25, n (%) | 51 (34.7) | 23 (41.8) | 58 (43.3) |
KPS, ≥ 90, n (%) | 53 (33.8) | 29 (50.9) | 56 (40.0) |
NRS2002, ≥ 2, n (%) | 93 (59.2) | 35 (61.4) | 84 (60.0) |
Tumor type, n (%) | |||
Glioma | 26 (16.6) | 21 (36.8) | 24 (17.1) |
Brain metastatic tumor | 102 (65.0) | 12 (21.1) | 62 (44.3) |
Meningioma | 9 (5.7) | 9 (15.8) | 24 (17.1) |
Sellar region tumor | 10 (6.4) | 2 (3.5) | 7 (5.0) |
Others | 10 (6.4) | 13 (22.8) | 23 (16.4) |
